Novartis Ag (NVS) EBIT Margin (2009 - 2026)
Novartis Ag's EBIT Margin came in at 32.97% for Q2 2026, down 1.64 percentage points from 34.61% a year earlier.
Powered by 
Analysis
Novartis Ag (NVS) EBIT Margin (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Novartis Ag reported EBIT Margin of 32.63%, down 0.11 percentage points year-over-year; for FY2025, it was 32.36%, up 3.45 percentage points from FY2024.
- EBIT Margin has increased in each of the last three years, with a five-year change of +11.49 percentage points (FY2020 to FY2025).
- Going back by year, EBIT Margin was 28.90% in FY2024 (+7.41 pp), 21.50% in FY2023 (+2.67 pp), 18.83% in FY2022 (-4.68 pp) and 23.51% in FY2021 (+2.64 pp).
- The Q2 2026 figure represents the lowest quarterly EBIT Margin since Q2 2024.
- The fastest year-over-year change in EBIT Margin over five years came in Q2 2024 (a gain of 7.54 percentage points), and the weakest in Q3 2022 (a drop of 10.25 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.90 Bn | 1,105.48 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.06 Bn | 535.59 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 501.38 Bn | 474.49 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 297.92 Bn | 261.91 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.31 Bn | 235.00 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 236.29 Bn | 191.69 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 190.40 Bn | 164.60 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 169.55 Bn | 116.19 Bn | 10.94 Bn | 28.37% |
| 10 | Vertex Pharmaceuticals | 133.66 Bn | 105.67 Bn | 2.84 Bn | 37.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.97% |
| Mar 31, 2026 | 32.30% |
| Dec 31, 2025 | 27.11% |
| Sep 30, 2025 | 32.36% |
| Jun 30, 2025 | 34.61% |
| Mar 31, 2025 | 35.24% |
| Dec 31, 2024 | 26.84% |
| Sep 30, 2024 | 28.29% |
| Jun 30, 2024 | 32.08% |
| Mar 31, 2024 | 28.51% |
| Dec 31, 2023 | 22.60% |
| Sep 30, 2023 | 14.96% |
| Jun 30, 2023 | 24.54% |
| Mar 31, 2023 | 24.25% |
| Dec 31, 2022 | 16.59% |
| Sep 30, 2022 | 17.40% |
| Jun 30, 2022 | 17.43% |
| Mar 31, 2022 | 22.76% |
| Dec 31, 2021 | 19.37% |
| Sep 30, 2021 | 24.81% |
API Access
Novartis Ag EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();